Karen McCoy
Pediatric Pulmonology · Columbus, OHNPI 1487648887
Payments from drug & device makers
What this record shows
Vertex accounts for 92.4% of it on its own, with 1 other manufacturer making up the rest.
Across 15 payments — averaging $79.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Vertex$1K
- Abiomed$91
Across 129 payments — averaging $15,693 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Vertex$1.8M
- Novoteris, LLC$129K
- AbbVie$91K
- Boehringer Ingelheim$34K
- Insmed, Inc.$11K
- Boehringer Ingelheim Italia S.p.a.$3K
What the payments were for
- Travel & lodging$60751%
- Food & beverage$58949%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$1,196 in reported general payments places this provider in the 65th percentile of 68 pediatric pulmonology providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Glycopyrrolate | 13 | $591 |
Paid to pharmacies, not to this prescriber.
Other pediatric pulmonology in Columbus
- Richard ShellColumbus$44K
- Katelyn KrivcheniaColumbus$3K
- John HeintzColumbus$526
- Don HayesColumbus$344
- Kavitha KothaColumbus$227
- Grace PaulColumbus$227
- Alpa PatelColumbus$191
- Stephen KirkbyColumbus$128
- Sehyr ImranColumbus$53
- Theresa GuilbertCincinnati$152K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.